Chronic Pain

  • Do you currently experience periodic or chronic pain?
  • Are you currently taking a medications that have proven to disappoint expectations?
  • Have you set an intention to reduce a dependency on opiates and other pain relievers?

I have exciting news for you. A new CTFO product is available as of this week  which has been formulated to address the struggles  of people who experience chronic pain. If your answer to any one of the three questions above is yes, please take 3  minutes to watch the video posted on the CTFO website.

https://myctfocbd.com/parkinsonsrecovery/

Like most opiates the  newly formulated 10XPure 1000 Gold CBD product CBDA is a COX-2 inhibitor which leads to the relief of pain and swelling. I recently heard a presentation by neurologist Stephen Trobiani who predicts that this new product development may well  offer a welcome solution to anyone who suffers from persistent and chronic pain and is interested in avoiding opiates as a solution.

Of course we have no evidence at this point on whether this new product discovery will offer sustained pain relief, but I believe it is worth taking seriously and investigating further.  The company – CTFO – that developed it is one that I have no hesitation in recommending. They are a first class act.

For more information on CBDA (and how it differs from CBD) visit:

https://myctfocbd.com/parkinsonsrecovery/

Now – a big reason I have no hesitation with a recommendation that you consider trying a new product for which we have no solid feedback yet is that CTFO offers a full, 60 day money back guarantee. Return the used, empty bottle within 60 days after purchase and receive a full 100% refund.

If you decide to give this one a try, please let me know the outcome!

Robert Rodgers PhD
Founder
Parkinsons Recovery
Road to Recovery from Parkinsons Disease
https://www.parkinsonsdisease.me

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.